Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group
Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group French pharma services provider, Clean Biologics, has acquired Canadian CDMO, Biodextris, in a move it says will boost its analytical and process development, and early-phase clinical manufacturing and quality control testing services for clients in the vaccine and biologics industries. The move also means it gets a platform to establish a presence on the North American market with a view to increasing its activities in this region. The financial terms of the t...